Interestingly, downregulation of Bit1 expression in tumor cells conferred enhanced cellular migratory function and mesenchymal phenotype and was associated with loss of E-cadherin and upregulation of N-cadherin expression [11]. Here, PTRH2 is linked to neoplasm.